These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21440975)

  • 1. New challenges for the pulmonologist in the diagnosis of latent tuberculosis infection: biological treatment and pulmonary tuberculosis.
    Hernández González F; Sanz Herrero F; Lloret Pérez T
    Arch Bronconeumol; 2011 Jul; 47(7):375. PubMed ID: 21440975
    [No Abstract]   [Full Text] [Related]  

  • 2. Miliary tuberculosis following negative latent tuberculosis infection screening prior to tumor necrosis factor-α antagonists: implications for management?
    Teh BW; Street AC; McBryde ES; Denholm JT
    J Rheumatol; 2012 Jun; 39(6):1297-8. PubMed ID: 22661422
    [No Abstract]   [Full Text] [Related]  

  • 3. A case of latent tuberculosis reactivation in a patient treated with ustekinumab without concomitant isoniazid chemoprophylaxis in the PEARL trial.
    Tsai TF; Chiu HY; Song M; Chan D
    Br J Dermatol; 2013 Feb; 168(2):444-6. PubMed ID: 22816505
    [No Abstract]   [Full Text] [Related]  

  • 4. Recurrence of active tuberculosis following resumption of anti-TNF-α therapy in a patient with Crohn's disease.
    Masiá M; Martínez M; García-Sepulcre MF; Sáez J; Gutiérrez F
    Int J Tuberc Lung Dis; 2014 Feb; 18(2):249-50. PubMed ID: 24429322
    [No Abstract]   [Full Text] [Related]  

  • 5. Pulmonary sarcoidosis and latent tuberculosis in a patient with psoriasis treated with adalimumab.
    Korta DZ; Ochieng P; Fishman D; Katz SE
    Dermatol Online J; 2015 Jan; 21(1):. PubMed ID: 25612132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should tuberculin skin test be positive to give latent tuberculosis treatment before tumor necrosis factor-alpha inhibitors in selected patients in developing countries?
    Abud-Mendoza C; Martínez-Martínez MU; DE Jesús Macías-Mendoza J; Magaña-Aquino M
    J Rheumatol; 2010 Mar; 37(3):672-3; author reply 673. PubMed ID: 20197567
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnosing latent tuberculosis infection in patients with psoriasis under antitumour necrosis factor-α treatment: every new solution breeds new doubts.
    Sánchez-Moya AI; Daudén E
    Br J Dermatol; 2011 Jan; 164(1):208-9. PubMed ID: 21054332
    [No Abstract]   [Full Text] [Related]  

  • 8. Guidelines for screening, prophylaxis and critical information prior to initiating anti-TNF-alpha treatment.
    Nordgaard-Lassen I; Dahlerup JF; Belard E; Gerstoft J; Kjeldsen J; Kragballe K; Ravn P; Sørensen IJ; Theede K; Tjellesen L;
    Dan Med J; 2012 Jul; 59(7):C4480. PubMed ID: 22759856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory symptoms in a patient on anti-tumour necrosis factor therapy; beware the negative enzyme linked immuno-spot (ELISpot) in suspected mycobacterial disease.
    Mangat P; Taylor P; Abraham S
    QJM; 2011 Jan; 104(1):61-3. PubMed ID: 20504863
    [No Abstract]   [Full Text] [Related]  

  • 10. Double screening for latent tuberculosis infection in patients treated with anti-tumor necrosis factor α.
    Sempau L; González-Sixto B; Sánchez-Sambucetty P; de Morales JM; Pérez-Bustillo A; Rodríguez-Prieto MA
    Arch Dermatol; 2011 Oct; 147(10):1233-4. PubMed ID: 22006153
    [No Abstract]   [Full Text] [Related]  

  • 11. Challenges in diagnosing latent tuberculosis infection in patients treated with tumor necrosis factor antagonists.
    Keystone EC; Papp KA; Wobeser W
    J Rheumatol; 2011 Jul; 38(7):1234-43. PubMed ID: 21459944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Etanercept and infection - latent tuberculosis].
    González-Sixto B; Rodríguez-Prieto MA
    Actas Dermosifiliogr; 2010 May; 101 Suppl 1():62-9. PubMed ID: 20492883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience of QuantiFERON(®) -TB Gold testing in patients with psoriasis treated with tumour necrosis factor blockers in Taiwan.
    Chiu HY; Hsueh PR; Tsai TF
    Br J Dermatol; 2011 Mar; 164(3):553-9. PubMed ID: 21083541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disseminated tuberculosis secondary to adalimumab.
    Pednekar M; Chandra AB; Chandra PA
    Am J Ther; 2012 Jul; 19(4):e139-40. PubMed ID: 20838203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of latent tuberculosis infection (LTBI) before anti-TNF-alpha treatment--the tuberculin skin test is useful.
    Goujon C; Nosbaum A; Bensaid B; Rozières A; Nicolas JF; Bérard F
    Eur J Dermatol; 2012; 22(5):701-2. PubMed ID: 23032063
    [No Abstract]   [Full Text] [Related]  

  • 16. Tumor necrosis factor-alpha blocker induced tuberculosis.
    Kharbanda P; Dagaonkar R; Balakrishnan C; Udwadia ZF
    J Rheumatol; 2010 Jul; 37(7):1542; author reply 1543. PubMed ID: 20595292
    [No Abstract]   [Full Text] [Related]  

  • 17. Latent tuberculosis: interferon and beyond?
    Persing DH
    J Mol Diagn; 2015 Jan; 17(1):2-3. PubMed ID: 25528186
    [No Abstract]   [Full Text] [Related]  

  • 18. Interferon-inducible protein-10 as a marker to detect latent and active tuberculosis in rheumatoid arthritis.
    Chen DY; Shen GH; Chen YM; Chen HH; Lin CC; Hsieh CW; Lan JL
    Int J Tuberc Lung Dis; 2011 Feb; 15(2):192-200. PubMed ID: 21219680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The relevance of diagnostic criteria for latent tuberculosis before initiation of TNF-alpha inhibitors in psoriasis patients].
    Goujon C; Gormand F; Gunera-Saad N; Dahel K; Vial T; Nicolas JF
    Ann Dermatol Venereol; 2010; 137(6-7):437-43. PubMed ID: 20620572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive conversion of tuberculin skin test and performance of interferon release assay to detect hidden tuberculosis infection during anti-tumor necrosis factor agent trial.
    Park JH; Seo GY; Lee JS; Kim TH; Yoo DH
    J Rheumatol; 2009 Oct; 36(10):2158-63. PubMed ID: 19723901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.